Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum
Stevanato Group (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions for pharmaceutical, biotechnology, and life sciences industries, has announced its participation in the KeyBanc Capital Markets Healthcare Forum.
The event is scheduled for March 18-19, 2025, with the company's presentation set for Tuesday, March 18, at 3:00 p.m. ET. Investors and interested parties can access the live webcast through the 'Investors' section of Stevanato's website at www.stevanatogroup.com. The presentation recording will remain available for approximately 90 days following the event.
Stevanato Group (NYSE: STVN), un fornitore globale leader di soluzioni per la contenimento dei farmaci, la somministrazione dei farmaci e la diagnostica per le industrie farmaceutiche, biotecnologiche e delle scienze della vita, ha annunciato la sua partecipazione al KeyBanc Capital Markets Healthcare Forum.
L'evento è programmato per il 18-19 marzo 2025, con la presentazione dell'azienda fissata per martedì 18 marzo alle 15:00 ET. Gli investitori e le parti interessate possono accedere alla diretta streaming attraverso la sezione 'Investitori' del sito web di Stevanato all'indirizzo www.stevanatogroup.com. La registrazione della presentazione rimarrà disponibile per circa 90 giorni dopo l'evento.
Stevanato Group (NYSE: STVN), un proveedor global líder de soluciones de contención de fármacos, entrega de fármacos y diagnóstico para las industrias farmacéutica, biotecnológica y de ciencias de la vida, ha anunciado su participación en el KeyBanc Capital Markets Healthcare Forum.
El evento está programado para el 18-19 de marzo de 2025, con la presentación de la empresa programada para el martes 18 de marzo a las 3:00 p.m. ET. Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través de la sección 'Inversores' en el sitio web de Stevanato en www.stevanatogroup.com. La grabación de la presentación estará disponible durante aproximadamente 90 días después del evento.
Stevanato Group (NYSE: STVN)는 제약, 생명공학 및 생명 과학 산업을 위한 의약품 포장, 의약품 전달 및 진단 솔루션의 글로벌 선두 제공업체로, KeyBanc Capital Markets Healthcare Forum에 참여한다고 발표했습니다.
이 행사는 2025년 3월 18일부터 19일까지 예정되어 있으며, 회사의 발표는 3월 18일 화요일 오후 3시(ET)에 예정되어 있습니다. 투자자 및 관심 있는 분들은 Stevanato의 웹사이트 www.stevanatogroup.com의 '투자자' 섹션을 통해 라이브 웹캐스트에 접속할 수 있습니다. 발표 녹화는 행사 후 약 90일 동안 이용 가능합니다.
Stevanato Group (NYSE: STVN), un fournisseur mondial de premier plan de solutions de confinement des médicaments, de distribution des médicaments et de diagnostic pour les industries pharmaceutique, biotechnologique et des sciences de la vie, a annoncé sa participation au KeyBanc Capital Markets Healthcare Forum.
L'événement est prévu pour les 18 et 19 mars 2025, avec la présentation de l'entreprise prévue pour le mardi 18 mars à 15h00 ET. Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct via la section 'Investisseurs' du site Web de Stevanato à l'adresse www.stevanatogroup.com. L'enregistrement de la présentation sera disponible pendant environ 90 jours après l'événement.
Stevanato Group (NYSE: STVN), ein führender globaler Anbieter von Lösungen für die Arzneimittelverpackung, Arzneimittelabgabe und Diagnostik für die pharmazeutische, biotechnologische und Lebenswissenschaftsindustrie, hat seine Teilnahme am KeyBanc Capital Markets Healthcare Forum angekündigt.
Die Veranstaltung ist für den 18.-19. März 2025 geplant, wobei die Präsentation des Unternehmens für Dienstag, den 18. März, um 15:00 Uhr ET angesetzt ist. Investoren und interessierte Parteien können über den Bereich 'Investoren' auf der Website von Stevanato unter www.stevanatogroup.com auf den Live-Webcast zugreifen. Die Aufzeichnung der Präsentation wird etwa 90 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
PIOMBINO DESE,
The Company will present on Tuesday, March 18, at 3.00 p.m. (ET). A live webcast will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value-added solutions to clients.
For more information, please visit: www.stevanatogroup.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250311818351/en/
Media
Stevanato Group
media@stevanatogroup.com
Investor Relations
Lisa Miles
lisa.miles@stevanatogroup.com
Source: Stevanato Group
FAQ
When is Stevanato Group (STVN) presenting at the KeyBanc Capital Markets Healthcare Forum?
How can investors watch Stevanato Group's (STVN) KeyBanc Healthcare Forum presentation?
How long will Stevanato Group's (STVN) KeyBanc presentation replay be available?
What dates is the KeyBanc Capital Markets Healthcare Forum where STVN is presenting?
